Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Arterial prosthesis
Reexamination Certificate
2011-06-14
2011-06-14
Lukton, David (Department: 1654)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Arterial prosthesis
C623S001450, C530S350000, C530S359000, C424S422000, C424S423000, C514S001100, C514S016400, C514S021200
Reexamination Certificate
active
07959659
ABSTRACT:
An implantable medical device is disclosed comprising a high-density lipoprotein (HDL), recombinant HDL, high-density lipoprotein mimics (HDLm), or a combination thereof. Method are also disclosed for local and systemic administration HDL, recombinant HDL or HDLm for the prevention, treatment, or amelioration of a vascular disorder, disease or occlusion such as restenosis or vulnerable plaque.
REFERENCES:
patent: 4916193 (1990-04-01), Tang et al.
patent: 4994071 (1991-02-01), MacGregor
patent: 5092877 (1992-03-01), Pinchuk
patent: 5163952 (1992-11-01), Froix
patent: 5746223 (1998-05-01), Williams
patent: 5801141 (1998-09-01), Steber et al.
patent: 5858400 (1999-01-01), Williams
patent: 5861387 (1999-01-01), Labrie et al.
patent: 5928667 (1999-07-01), Rosenblatt et al.
patent: 5948435 (1999-09-01), Williams
patent: 6037323 (2000-03-01), Dasseux et al.
patent: 6046166 (2000-04-01), Dasseux et al.
patent: 6079416 (2000-06-01), Williams
patent: 6156727 (2000-12-01), Garber et al.
patent: 6265377 (2001-07-01), Dasseux et al.
patent: 6367479 (2002-04-01), Williams
patent: 6376464 (2002-04-01), Dasseux et al.
patent: 6514533 (2003-02-01), Burke et al.
patent: 6518412 (2003-02-01), Dasseux et al.
patent: 6548548 (2003-04-01), Campbell et al.
patent: 6573239 (2003-06-01), Dasseux et al.
patent: 6585995 (2003-07-01), Hanson
patent: 6602854 (2003-08-01), Dasseux et al.
patent: 6649362 (2003-11-01), Gamble et al.
patent: 6692759 (2004-02-01), Wong et al.
patent: 6905700 (2005-06-01), Won et al.
patent: 6916788 (2005-07-01), Seo et al.
patent: 6930111 (2005-08-01), Ibrahim et al.
patent: 6998388 (2006-02-01), Cockerill et al.
patent: 2003/0109442 (2003-06-01), Bisgaier et al.
patent: 2003/0216699 (2003-11-01), Falotico
patent: 2005/0025799 (2005-02-01), Hossainy et al.
patent: 2005/0070996 (2005-03-01), Dinh et al.
patent: 2005/0070997 (2005-03-01), Thornton et al.
patent: 2005/0074544 (2005-04-01), Pacetti et al.
patent: 2005/0074545 (2005-04-01), Thomas
patent: WO 03/026492 (2003-04-01), None
patent: WO 03/072159 (2003-09-01), None
Nissen (J. Am. Med. Assoc. 290, 2292-2300, 2003).
English abstract of Hu, J et al., (Yi Chaun Xue Bao 30(1), 20-24, 2003).
International Search Report and Written Opinion for PCT/US2004/043869 filed Dec. 29, 2004, mailed May 6, 2005, 15 pgs.
Von Birgelen et al., “Relation Between Progression and Regression of Atherosclerotic Left Main Coronary Artery Disease and Serum Cholesterol Levels as Assessed with Serial Long-Term (≧12 Month) Follow-Up Intravascular Ultrasound”, Circulation, Dec. 2, 2003, pp. 2757-2762.
Chiesa et al., Recombinant apolipoprotein A-IMilano:a novel agent for the induction of regression of atherosclerotic plaques, Annals of Med. 35(4): 267-273, 2003.
Chroni et al., “The Central Helices of ApoA-I Can Promote ATP-binding Cassette Transporter A1 (ABCA1)-mediated Lipid Efflux”, The J. Of Biol. Chem. vol. 278, No. 9, pp. 6719-6730, 2003.
Gorshkova et al., “Lipid-Free Structure and Stability of Apolipoprotein A-I: Probing the Central Region by Mutation”, Biochemistry, vol. 41, No. 33, pp. 10529-10539, 2002.
Hu et al, “Expression of the human extracellular domain of high density lipoprotein receptor in methylotropic yeast”, Yi Chuan Xue Bao, Jan; 30(1), 1 pg., 2003.
Khan et al., “Single-Dose Intravenous Infusion of ETC-642, a 22-Mar ApoA-1 Analogue and Phosphollpids Complex, Elevates HDL-C in Atherosclerosis Patients”, Circulation vol. 108, No. 17, 2570, Oct. 28, 2003.
Nissen et al., “Effect of Recombinant ApoA-1 Milano on Coronary Atherosclerosis in Patients with Acute Coronary Syndromes”, JAMA, vol. 290, No. 17, pp. 2292-2300, 2003.
Panagotopulos et al., “Bacterial expression and characterization of mature apolipoprotein A-1”, Protein Expression and Purification 25, pp. 353-361, 2002.
Perry et al., “Local Delivery of Antibiotics via an Implantable Pump in the Treatment of Osteomyelitis”, Clin. Orthop. 226: pp. 222-230, 1988.
Rensen et al., “Recombinant Lipoproteins: Lipoprotein-Like Lipid Particles for Drug Targeting”, Advanced Drug Delivery Reviews, vol. 47, pp. 251-276, Apr. 25, 2001.
Tailleux et al., “Apolipoprotein A-II, HDL metabolism and atherosclerosis”, Atherosclerosis 164, 13 pgs. 2002.
Tian et al., “Structural and functional properties of apolipoprotein A-I mutants containing disulfide-linked cysteines at positions 124 or 232”, Biochimica et Biophysica Acta 1599, pp. 56-64, 2002.
Advanced Cardiovascular Systems Inc.
Lukton David
Squire Sanders & Dempsey (US) LLP
LandOfFree
High-density lipoprotein coated medical devices does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with High-density lipoprotein coated medical devices, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High-density lipoprotein coated medical devices will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2738532